Jing Zhang

Clinical Pharmacology of Cyclophosphamide and Ifosfamide

Shufeng Zhou, Quan Tian, Jing Zhang, 2006 .

Insights into oxazaphosphorine resistance and possible approaches to its circumvention.

Shufeng Zhou, S. Chan, W. Duan, 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Interaction of Oxazaphosphorines with Multidrug Resistance-Associated Protein 4 (MRP4)

P. Ho, K. Ng, Jing Zhang, 2010, The AAPS Journal.

Topotecan is a substrate for multidrug resistance associated protein 4.

M. Huang, Qiang Yu, Shufeng Zhou, 2006, Current drug metabolism.

A Mechanistic Study of the Intestinal Absorption of Cryptotanshinone, the Major Active Constituent of Salvia miltiorrhiza

M. Huang, Shufeng Zhou, S. Chan, 2006, Journal of Pharmacology and Experimental Therapeutics.

Reversal of resistance to oxazaphosphorines.

Shufeng Zhou, Quan Tian, Yi-Zhun Zhu, 2006, Current cancer drug targets.

Metabolism and Transport of Oxazaphosphorines and the Clinical Implications

Shufeng Zhou, W. Duan, Quan Tian, 2005, Drug metabolism reviews.

Human Multidrug Resistance Associated Protein 4 Confers Resistance to Camptothecins

Shufeng Zhou, S. Chan, E. Chan, 2005, Pharmaceutical Research.

Multidrug resistance proteins (MRPs) and implication in drug development

Shufeng Zhou, E. Chan, W. Duan, 2005 .